Active Biotech AB (publ) (STO:ACTI)
Sweden · Delayed Price · Currency is SEK 0.0482
+0.0002 (0.42%)
At close: Mar 4, 2026
Active Biotech AB Market Cap
Active Biotech AB has a market cap or net worth of 127.06 million as of March 4, 2026. Its market cap has increased by 17.64% in one year.
Market Cap
127.06M
Enterprise Value
118.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since March 11, 1998, Active Biotech AB's market cap has decreased from 693.06M to 127.06M, a decrease of -81.67%. That is a compound annual growth rate of -5.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 127.06M | 4.78% |
| Dec 30, 2025 | 121.26M | 4.60% |
| Dec 30, 2024 | 115.93M | -29.80% |
| Dec 29, 2023 | 165.13M | -35.20% |
| Dec 30, 2022 | 254.82M | -7.51% |
| Dec 30, 2021 | 275.52M | 0.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 193.96M |
| Magle Chemoswed Holding AB | 163.13M |
| NextCell Pharma AB | 145.03M |
| IRLAB Therapeutics AB | 138.28M |
| Simris Group AB (PUBL) | 134.98M |
| Xbrane Biopharma AB | 122.00M |
| Annexin Pharmaceuticals AB | 102.36M |
| Biovica International AB | 101.59M |